IRD — Opus Genetics, Inc. stock price, charts and financials

QT66Opus Genetics, Inc.

Opus Genetics, Inc. (NASDAQ: IRD) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.71
+0.07+1.92%
OverviewShort InterestFilings
IRDQT66Opus Genetics, Inc.·NASDAQ
3.71+1.92%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jun 17, 2026424B2Prospectus
Jun 16, 20268-KCurrent report
Jun 16, 20268-KCurrent report
Jun 15, 2026EFFECTNotice of effectiveness
Jun 05, 2026S-3Shelf registration statement
May 20, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 20, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026S-8Registration of employee benefit securities
May 13, 2026SC 13GBeneficial ownership statement (passive)
May 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
Apr 27, 20264Statement of changes in beneficial ownership
Apr 27, 20264Statement of changes in beneficial ownership
Apr 27, 20264Statement of changes in beneficial ownership
Apr 27, 20264Statement of changes in beneficial ownership
Apr 27, 20264Statement of changes in beneficial ownership
#1 / 25 of 354
Page
▼
/ 15